A phase II study of isoflavone, gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer

被引：0
|
作者：
Hammad, N.
Philip, P. A.
Shields, A. F.
Sarkar, F. H.
Abruzzese, J. L.
Kaseb, A. O.
Javle, M. M.
Varadhachary, G. R.
Wolff, R. A.
El-Rayes, B. F.
机构：
[1] Karmanos Canc Ctr, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15540
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
    E Van Cutsem
    C-P Li
    E Nowara
    G Aprile
    M Moore
    I Federowicz
    J-L Van Laethem
    C Hsu
    C K Tham
    S M Stemmer
    R Lipp
    A Zeaiter
    A Fittipaldo
    Z Csutor
    B Klughammer
    X Meng
    T Ciuleanu
    British Journal of Cancer, 2014, 111 : 2067 - 2075
  • [32] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
    Sanghvi, Samrat M.
    Coffman, Alex R.
    Hsueh, Chung-Tsen
    Kang, Joseph
    Park, Annie
    Solomon, Naveenraj L.
    Garberoglio, Carlos A.
    Reeves, Mark E.
    Slater, Jerry D.
    Yang, Gary Y.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
  • [33] Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
    Richards, Donald A.
    Kuefler, Paul R.
    Becerra, Carlos
    Wilfong, Lalan S.
    Gersh, Robert H.
    Boehm, Kristi A.
    Zhan, Feng
    Asmar, Lina
    Myrand, Scott P.
    Hozak, Rebecca R.
    Zhao, Luping
    Gill, John F.
    Mullaney, Brian P.
    Obasaju, Coleman K.
    Nicol, Steven J.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (01) : 144 - 153
  • [34] Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
    Donald A. Richards
    Paul R. Kuefler
    Carlos Becerra
    Lalan S. Wilfong
    Robert H. Gersh
    Kristi A. Boehm
    Feng Zhan
    Lina Asmar
    Scott P. Myrand
    Rebecca R. Hozak
    Luping Zhao
    John F. Gill
    Brian P. Mullaney
    Coleman K. Obasaju
    Steven J. Nicol
    Investigational New Drugs, 2011, 29 : 144 - 153
  • [35] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma
    Jo, J.
    Lee, H.
    Park, S.
    Chung, D.
    Cho, S.
    Cha, H.
    Cho, J.
    Song, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S211 - S211
  • [38] Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results
    Solda, C.
    Bardini, R.
    Sperti, C.
    Da Dalt, G.
    Gion, M.
    Fiduccia, P.
    Ursini, F.
    Aliberti, C.
    Pastorelli, D.
    ANNALS OF ONCOLOGY, 2015, 26 : 102 - 102
  • [39] Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: A phase I-II study
    Oliani, C
    Padovani, M
    Manno, P
    Barana, D
    Falconi, M
    Bassi, C
    Cavallini, G
    Pederzoli, P
    Cetto, GL
    ANTICANCER RESEARCH, 2004, 24 (3B) : 2107 - 2112
  • [40] Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer A Phase II Study
    Safran, Howard
    Miner, Thomas
    Bahary, Nathan
    Whiting, Sam
    Lopez, Charles D.
    Sun, Weijing
    Charpentier, Kevin
    Shipley, Joshua
    Anderson, Elliot
    McNulty, Brendan
    Schumacher, Andrew
    Clark, Alessandra
    Vakharia, Jamsheed
    Kennedy, Teresa
    Sio, Terence
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 50 - 52
12345